Surgical Science Sweden Stock Fundamentals
| SUSRF Stock | USD 14.50 0.00 0.00% |
Surgical Science Sweden fundamentals help investors to digest information that contributes to Surgical Science's financial success or failures. It also enables traders to predict the movement of Surgical Pink Sheet. The fundamental analysis module provides a way to measure Surgical Science's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Surgical Science pink sheet.
Surgical |
Surgical Science Sweden Company Return On Equity Analysis
Surgical Science's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Surgical Science Return On Equity | 0.0357 |
Most of Surgical Science's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgical Science Sweden is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Surgical Science Sweden has a Return On Equity of 0.0357. This is 100.15% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The return on equity for all United States stocks is 111.52% lower than that of the firm.
Surgical Science Sweden Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Surgical Science's current stock value. Our valuation model uses many indicators to compare Surgical Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surgical Science competition to find correlations between indicators driving Surgical Science's intrinsic value. More Info.Surgical Science Sweden is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers reporting about 0.59 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Surgical Science Sweden is roughly 1.68 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Surgical Science's earnings, one of the primary drivers of an investment's value.Surgical Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgical Science's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Surgical Science could also be used in its relative valuation, which is a method of valuing Surgical Science by comparing valuation metrics of similar companies.Surgical Science is currently under evaluation in return on equity category among its peers.
Surgical Fundamentals
| Return On Equity | 0.0357 | |||
| Return On Asset | 0.0212 | |||
| Profit Margin | 0.18 % | |||
| Current Valuation | 743.09 M | |||
| Shares Outstanding | 50.8 M | |||
| Shares Owned By Insiders | 32.75 % | |||
| Shares Owned By Institutions | 52.03 % | |||
| Price To Earning | 73.41 X | |||
| Price To Book | 2.26 X | |||
| Price To Sales | 15.43 X | |||
| Revenue | 366.78 M | |||
| Gross Profit | 265.94 M | |||
| EBITDA | 122.27 M | |||
| Net Income | 86.25 M | |||
| Total Debt | 29.42 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 2.66 X | |||
| Cash Flow From Operations | 39.08 M | |||
| Earnings Per Share | 0.28 X | |||
| Number Of Employees | 233 | |||
| Beta | 0.94 | |||
| Market Capitalization | 833.72 M | |||
| Total Asset | 3.98 B | |||
| Z Score | 16.8 | |||
| Net Asset | 3.98 B |
About Surgical Science Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgical Science Sweden's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgical Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgical Science Sweden based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Surgical Science Sweden AB develops and markets virtual reality simulators for evidence-based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Surgical Pink Sheet
Surgical Science financial ratios help investors to determine whether Surgical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Surgical with respect to the benefits of owning Surgical Science security.